IFN-gamma drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy. Li X, Aguilar-Navarro AG, Nader M, Jahangiri S, et al. Blood 2026;148:1277-1291.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Aguilar-Navarro AG, Nader M, Jahangiri S, et al. IFN-gamma drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy. Blood 2026;148:1277-1291.
PMID: 42008378